The perceptions of natural compounds against dipeptidyl peptidase 4 in diabetes: from to

• Main Authors: Shian-Ren Lin (Author), Chia-Hsiang Chang (Author), May-Jwan Tsai (Author), Henrich Cheng (Author), Jian-Chyi Chen (Author), Max K. Leong (Author), Ching-Feng Weng (Author)
• Format: Book
• Published: SAGE Publishing, 2019-09-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Dipeptidyl peptidase IV (DPP-4), an incretin glucagon-like peptide-1 (GLP-1) degrading enzyme, contains two forms and it can exert various physiological functions particular in controlling blood glucose through the action of GLP-1. In diabetic use, the DPP-4 inhibitor can block the DDP-4 to attenuat...